Molecular and Cellular Crosstalk between Bone and Brain: Accessing Bidirectional Neural and Musculoskeletal Signaling during Aging and Disease

참고문헌 (222)

1. Aebersold R, "Mass-spectrometric exploration of proteome structure and function", Nature, 537, pp.347~355 (2016)[DOI]
2. Bell PA, "Proteomic and N-Terminomic TAILS analyses of human alveolar bone proteins : Improved protein extraction methodology and LysargiNase digestion strategies increase proteome coverage and missing protein identification", J Proteome Res, 18, pp.4167~4179 (2019)[DOI]
3. Safiri S, "Global, regional, and national burden of neck pain in the general population, 1990-2017: systematic analysis of the Global Burden of Disease Study 2017", BMJ, 368, pp.m791~ (2020)[DOI]
4. Vos T, "Years lived with disability(YLDs)for 1160 sequelae of 289 diseases and injuries 1990-2010 : a systematic analysis for the Global Burden of Disease Study 2010", Lancet, 380, pp.2163~2196 (2012)[DOI]
5. Sarafrazi N, "Osteoporosis or low bone mass in older adults: United States, 2017-2018", NCHS Data Brief, pp.1~8 (2021)
6. Salari N, "The global prevalence of osteoporosis in the world : a comprehensive systematic review and meta-analysis", J Orthop Surg Res, 16, pp.609~ (2021)[DOI]
7. Matthews KA, "Racial and ethnic estimates of Alzheimer's disease and related dementias in the United States(2015-2060)in adults aged ≥65 years", Alzheimers Dement, 15, pp.17~24 (2019)[DOI]
8. Global status report on the public health response to dementia, "World Health Organization", World Health Organization, ~ (2021)
9. Dimitri P, "The central nervous system and bone metabolism : An evolving story", Calcif Tissue Int, 100, pp.476~485 (2017)[DOI]
10. Takeda S, "Leptin regulates bone formation via the sympathetic nervous system", Cell, 111, pp.305~317 (2002)[DOI]
11. Elefteriou F, "Leptin regulation of bone resorption by the sympathetic nervous system and CART", Nature, 434, pp.514~520 (2005)[DOI]
12. Guo X, "Dkk1 : A promising molecule to connect Alzheimer's disease and osteoporosis", Med Hypotheses, 88, pp.30~32 (2016)[DOI]
13. Yuan J, "The potential influence of bone-derived modulators on the progression of Alzheimer’s disease", J Alzheimers Dis, 69, pp.59~70 (2019)[DOI]
14. Bien-Ly N, "Lack of widespread BBB disruption in Alzheimer’s disease models : Focus on therapeutic antibodies", Neuron, 88, pp.289~297 (2015)[DOI]
15. Otto E, "Crosstalk of brain and bone-clinical observations and their molecular bases", Int J Mol Sci, 21 (2020)[DOI]
16. Cooper RR, "Morphology of the osteon. An electron microscopic study", J Bone Joint Surg Am, 48, pp.1239~1271 (1966)
17. Cooper RR, "Nerves in cortical bone", Science, 160, pp.327~328 (1968)[DOI]
18. Tomlinson RE, "The role of nerves in skeletal development, adaptation, and aging", Front Endocrinol(Lausanne), 11, pp.646~ (2020)[DOI]
19. Lorenz MR, "A neuroskeletal atlas : Spatial mapping and contextualization of axon subtypes innervating the long bones of C3H and B6 mice", J Bone Miner Res, 36, pp.1012~1025 (2021)[DOI]
20. Morris JC, "Senile dementia of the Alzheimer’s type : an important risk factor for serious falls", J Gerontol, 42, pp.412~417 (1987)[DOI]
21. MacDonald JB, "Nocturnal femoral fracture and continuing widespread use of barbiturate hypnotics", Br Med J, 2, pp.483~485 (1977)[DOI]
22. Ray WA, "Psychotropic drug use and the risk of hip fracture", N Engl J Med, 316, pp.363~369 (1987)[DOI]
23. Perkins R, "Callus formation and the rate of healing of femoral fractures in patients with head injuries", J Bone Joint Surg Br, 69, pp.521~524 (1987)[DOI]
24. Spencer RF, "The effect of head injury on fracture healing. A quantitative assessment", J Bone Joint Surg Br, 69, pp.525~528 (1987)[DOI]
25. Ebendal T, "Bone morphogenetic proteins and their receptors : potential functions in the brain", J Neurosci Res, 51, pp.139~146 (1998)[DOI]
26. Krieglstein K, "Neural functions of the transforming growth factors beta", Int J Dev Neurosci, 13, pp.301~315 (1995)[DOI]
27. Melton LJ, 3rd, "Fracture risk in patients with Alzheimer's disease", J Am Geriatr Soc, 42, pp.614~619 (1994)[DOI]
28. Johnell O, "Fracture risk in patients with parkinsonism: a population-based study in Olmsted County, Minnesota", Age Ageing, 21, pp.32~38 (1992)[DOI]
29. Melton LJ 3rd, "Fracture risk after the diagnosis of Parkinson’s disease : Influence of concomitant dementia", Mov Disord, 21, pp.1361~1367 (2006)[DOI]
30. Huang SW, "Osteoarthritis increases the risk of dementia : a nationwide cohort study in Taiwan", Sci Rep, 5, pp.10145~ (2015)[DOI]
31. Nüesch E, "All cause and disease specific mortality in patients with knee or hip osteoarthritis : population based cohort study", BMJ, 342, pp.d1165~ (2011)[DOI]
32. Weller I, "Hip fractures and Alzheimer’s disease in elderly institutionalized Canadians", Ann Epidemiol, 14, pp.319~324 (2004)[DOI]
33. Tsai CH, "Fracture as an independent risk factor of dementia : a nationwide population-based cohort study", Medicine(Baltimore), 93, pp.e188~ (2014)[DOI]
34. Zhao Y, "Alzheimer's disease and risk of hip fracture : a meta-analysis study", ScientificWorldJournal, 2012, pp.872173~ (2012)[DOI]
35. Bae IS, "Association between bone mineral density and brain parenchymal atrophy and ventricular enlargement in healthy individuals", Aging(Albany NY), 11, pp.8217~8238 (2019)[DOI]
36. Weber A, "Association between osteoarthritis and increased risk of dementia : A systemic review and meta-analysis", Medicine(Baltimore), 98, pp.e14355~ (2019)[DOI]
37. Taylor CA, "Comorbid chronic conditions among older adults with subjective cognitive decline, United States, 2015-2017", Innov Aging, 4, pp.igz045~ (2020)[DOI]
38. Innes KE, "The association of perceived memory loss with osteoarthritis and related joint pain in a large appalachian population", Pain Med, 19, pp.1340~1356 (2018)[DOI]
39. Ikram M, "Association of osteoarthritis and pain with Alzheimer’s Diseases and Related Dementias among older adults in the United States", Osteoarthritis Cartilage, 27, pp.1470~1480 (2019)[DOI]
40. Wu L, "Association of osteoarthritis with changes in structural neuroimaging markers over time among non-demented older adults", Front Aging Neurosci, 13, pp.664443~ (2021)[DOI]
41. Kwon MJ, "The occurrence of Alzheimer’s disease and Parkinson’s disease in individuals with osteoporosis : A longitudinal follow-up study using a national health screening database in Korea", Front Aging Neurosci, 13, pp.786337~ (2021)[DOI]
42. Invernizzi M, "Osteoporosis in Parkinson’s disease", Parkinsonism Relat Disord, 15, pp.339~346 (2009)[DOI]
43. Costa de Miranda R, "Body composition and bone mineral density in Huntington’s disease", Nutrition, 59, pp.145~149 (2019)[DOI]
44. Goodman AO, "Body composition in premanifest Huntington’s disease reveals lower bone density compared to controls", PLoS Curr, 3, pp.Rrn1214~ (2011)[DOI]
45. Bajwa NM, "Long-term consequences of traumatic brain injury in bone metabolism", Front Neurol, 9, pp.115~ (2018)[DOI]
46. Yang TY, "The effects of an injury to the brain on bone healing and callus formation in young adults with fractures of the femoral shaft", J Bone Joint Surg Br, 94, pp.227~230 (2012)[DOI]
47. Cadosch D, "Humoral factors enhance fracture-healing and callus formation in patients with traumatic brain injury", J Bone Joint Surg Am, 91, pp.282~288 (2009)[DOI]
48. Smith É, "Prevalence of and risk factors for osteoporosis in adults with acquired brain injury", Ir J Med Sci, 185, pp.473~481 (2016)[DOI]
49. Locher RJ, "Traumatic brain injury and bone healing : Radiographic and biomechanical analyses of bone formation and stability in a combined murine trauma model", J Musculoskelet Neuronal Interact, 15, pp.309~315 (2015)
50. Yu H, "Reduced bone mass accrual in mouse model of repetitive mild traumatic brain injury", J Rehabil Res Dev, 51, pp.1427~1437 (2014)[DOI]
51. Tremblay M, "The role of microglia in the healthy brain", J Neurosci, 31, pp.16064~16069 (2011)[DOI]
52. Stevens B, "The classical complement cascade mediates CNS synapse elimination", Cell, 131, pp.1164~1178 (2007)[DOI]
53. Lee JW, "Two macrophages, osteoclasts and microglia: from development to pleiotropy", Bone Res, 9, pp.11~ (2021)[DOI]
54. Scheven BA, "In vitro osteoclast generation from different bone marrow fractions, including a highly enriched haematopoietic stem cell population", Nature, 321, pp.79~81 (1986)[DOI]
55. Wynn TA, "Macrophage biology in development, homeostasis and disease", Nature, 496, pp.445~455 (2013)[DOI]
56. Jacome-Galarza CE, "Developmental origin, functional maintenance and genetic rescue of osteoclasts", Nature, 568, pp.541~545 (2019)[DOI]
57. Gomez Perdiguero E, "Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors", Nature, 518, pp.547~551 (2015)[DOI]
58. Brody AH, "Alzheimer risk gene product Pyk2 suppresses tau phosphorylation and phenotypic effects of tauopathy", Mol Neurodegener, 17, pp.32~ (2022)[DOI]
59. Albagha OM, "Genome-wide association study identifies variants at CSF1, OPTN and TNFRSF11A as genetic risk factors for Paget’s disease of bone", Nat Genet, 42, pp.520~524 (2010)[DOI]
60. Hu B, "Insights Into the role of CSF1R in the central nervous system and neurological disorders", Front Aging Neurosci, 13, pp.789834~ (2021)[DOI]
61. Zhou M, "CCR5 is a suppressor for cortical plasticity and hippocampal learning and memory", Elife, 5 (2016)[DOI]
62. Mullin BH, "Characterisation of genetic regulatory effects for osteoporosis risk variants in human osteoclasts", Genome Biol, 21, pp.80~ (2020)[DOI]
63. de Pins B, "The non-receptor tyrosine kinase Pyk2 in brain function and neurological and psychiatric diseases", Front Synaptic Neurosci, 13, pp.749001~ (2021)[DOI]
64. Gil-Henn H, "Defective microtubule-dependent podosome organization in osteoclasts leads to increased bone density in Pyk2(-", -)mice, 2007, pp.178, 1053~1064
65. Humphrey MB, "TREM2, a DAP12-associated receptor, regulates osteoclast differentiation and function", J Bone Miner Res, 21, pp.237~245 (2006)[DOI]
66. Humphrey MB, "A comprehensive review of immunoreceptor regulation of osteoclasts", Clin Rev Allergy Immunol, 51, pp.48~58 (2016)[DOI]
67. Otero K, "TREM2 and β-catenin regulate bone homeostasis by controlling the rate of osteoclastogenesis", J Immunol, 188, pp.2612~2621 (2012)[DOI]
68. N’Diaye EN, "TREM-2(triggering receptor expressed on myeloid cells 2)is a phagocytic receptor for bacteria", J Cell Biol, 184, pp.215~223 (2009)[DOI]
69. Lue LF, "What happens to microglial TREM2 in Alzheimer’s disease : Immunoregulatory turned into immunopathogenic?", Neuroscience, 302, pp.138~150 (2015)[DOI]
70. Hsieh CL, "A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia", J Neurochem, 109, pp.1144~1156 (2009)[DOI]
71. Ren M, "TREM2 overexpression attenuates neuroinflammation and protects dopaminergic neurons in experimental models of Parkinson’s disease", Exp Neurol, 302, pp.205~213 (2018)[DOI]
72. Jiang T, "Upregulation of TREM2 ameliorates neuropathology and rescues spatial cognitive impairment in a transgenic mouse model of Alzheimer’s disease", Neuropsychopharmacology, 39, pp.2949~2962 (2014)[DOI]
73. Bekris LM, "Soluble TREM2 and biomarkers of central and peripheral inflammation in neurodegenerative disease", J Neuroimmunol, 319, pp.19~27 (2018)[DOI]
74. Mason DJ, "Mechanically regulated expression of a neural glutamate transporter in bone : a role for excitatory amino acids as osteotropic agents?", Bone, 20, pp.199~205 (1997)[DOI]
75. Turner CH, "Do bone cells behave like a neuronal network?", Calcif Tissue Int, 70, pp.435~442 (2002)[DOI]
76. Marner L, "Marked loss of myelinated nerve fibers in the human brain with age", J Comp Neurol, 462, pp.144~152 (2003)[DOI]
77. Buenzli PR, "Quantifying the osteocyte network in the human skeleton", Bone, 75, pp.144~150 (2015)[DOI]
78. Aird WC, "Spatial and temporal dynamics of the endothelium", J Thromb Haemost, 3, pp.1392~1406 (2005)[DOI]
79. Azevedo FA, "Equal numbers of neuronal and nonneuronal cells make the human brain an isometrically scaled-up primate brain", J Comp Neurol, 513, pp.532~541 (2009)[DOI]
80. Lent R, "How many neurons do you have? Some dogmas of quantitative neuroscience under revision", Eur J Neurosci, 35, pp.1~9 (2012)[DOI]
81. Zimmer C, "100 trillion connections", Sci Am, 304, pp.58~63 (2011)[DOI]
82. DeWeerdt S, "How to map the brain", Nature, 571, pp.S6~s8 (2019)[DOI]
83. Dai J, "Membrane tension in swelling and shrinking molluscan neurons", J Neurosci, 18, pp.6681~6692 (1998)[DOI]
84. Fornito A, "The connectomics of brain disorders", Nat Rev Neurosci, 16, pp.159~172 (2015)[DOI]
85. Fornito A, "Connectomics : A new paradigm for understanding brain disease", Eur Neuropsychopharmacol, 25, pp.733~748 (2015)[DOI]
86. Bock DD, "Network anatomy and in vivo physiology of visual cortical neurons", Nature, 471, pp.177~182 (2011)[DOI]
87. Kollmannsberger P, "The small world of osteocytes : Connectomics of the lacuno-canalicular network in bone", New J Phys, 19, pp.073019~ (2017)[DOI]
88. Weinkamer R, "Towards a connectomic description of the osteocyte lacunocanalicular network in bone", Curr Osteoporos Rep, 17, pp.186~194 (2019)[DOI]
89. Schurman CA, "Disrupted osteocyte connectivity and pericellular fluid flow in bone with aging and defective TGF-β signaling", Proc Natl Acad Sci U S A, 118 (2021)[DOI]
90. Knothe Tate ML, "Connectomics of bone to brain-probing physical renderings of cellular experience", Front Physiol, 12, pp.647603~ (2021)[DOI]
91. Tavee J, "Encyclopedia of the neurological sciences", pp.327~332 (2014), Academic Press
92. Robling AG, "Mechanical signaling for bone modeling and remodeling", Crit Rev Eukaryot Gene Expr, 19, pp.319~338 (2009)[DOI]
93. Schaffler MB, "Osteocyte signaling in bone", Curr Osteoporos Rep, 10, pp.118~125 (2012)[DOI]
94. Wang L, "Mechanical sensing protein PIEZO1 regulates bone homeostasis via osteoblast-osteoclast crosstalk", Nat Commun, 11, pp.282~ (2020)[DOI]
95. Gerosa L, "Bone-to-brain : A round trip in the adaptation to mechanical stimuli", Front Physiol, 12, pp.623893~ (2021)[DOI]
96. Alto LT, "Semaphorins and their signaling mechanisms", Methods Mol Biol, 1493, pp.1~25 (2017)[DOI]
97. Zhang M, "Semaphorin3A induces nerve regeneration in the adult cornea-a switch from its repulsive role in development", PLoS One, 13, pp.e0191962~ (2018)[DOI]
98. Fukuda T, "Correction : Corrigendum : Sema3A regulates bone-mass accrual through sensory innervations", Nature, 497, pp.490~493 (2013)[DOI]
99. Niimura M, "Semaphorin 3A promotes dendrite elongation of osteocytes in association with down-regulation of CDK6", In Vivo, 30, pp.231~236 (2016)
100. Hayashi M, "Autoregulation of osteocyte sema3A orchestrates estrogen action and counteracts bone aging", Cell Metab, 29, pp.627~637.e5 (2019)[DOI]
101. Wang JS, "Control of osteocyte dendrite formation by Sp7 and its target gene osteocrin", Nat Commun, 12, pp.6271~ (2021)[DOI]
102. Thorsell A, "Neuropeptide Y in alcohol addiction and affective disorders", Front Endocrinol(Lausanne), 8, pp.178~ (2017)[DOI]
103. Yi M, "A promising therapeutic target for metabolic diseases : Neuropeptide Y receptors in humans", Cell Physiol Biochem, 45, pp.88~107 (2018)[DOI]
104. Zhang Y, "Regulation of neuropeptide Y in body microenvironments and its potential application in therapies : a review", Cell Biosci, 11, pp.151~ (2021)[DOI]
105. Hashiguchi H, "Direct versus indirect actions of ghrelin on hypothalamic NPY neurons", PLoS One, 12, pp.e0184261~ (2017)[DOI]
106. Baldock PA, "Neuropeptide Y knockout mice reveal a central role of NPY in the coordination of bone mass to body weight", PLoS One, 4, pp.e8415~ (2009)[DOI]
107. Kohno D, "Ghrelin directly interacts with neuropeptide-Y-containing neurons in the rat arcuate nucleus : Ca2+ signaling via protein kinase A and N-type channel-dependent mechanisms and cross-talk with leptin and orexin", Diabetes, 52, pp.948~956 (2003)[DOI]
108. Zhang Y, "Neuronal induction of bone-fat imbalance through osteocyte neuropeptide Y", Adv Sci(Weinh), 8, pp.e2100808~ (2021)[DOI]
109. Matic I, "Bone-specific overexpression of NPY modulates osteogenesis", J Musculoskelet Neuronal Interact, 12, pp.209~218 (2012)
110. Lee NJ, "Osteoblast specific Y1 receptor deletion enhances bone mass", Bone, 48, pp.461~467 (2011)[DOI]
111. Igwe JC, "Neuropeptide Y is expressed by osteocytes and can inhibit osteoblastic activity", J Cell Biochem, 108, pp.621~630 (2009)[DOI]
112. Huang Y, "Neuropeptide Y and metabolism syndrome : An update on perspectives of clinical therapeutic intervention strategies", Front Cell Dev Biol, 9, pp.695623~ (2021)[DOI]
113. Shi YC, "NPY neuron-specific Y2 receptors regulate adipose tissue and trabecular bone but not cortical bone homeostasis in mice", PLoS One, 5, pp.e11361~ (2010)[DOI]
114. Panaroni C, "Mesenchymal progenitors and the osteoblast lineage in bone marrow hematopoietic niches", Curr Osteoporos Rep, 12, pp.22~32 (2014)[DOI]
115. Long F, "Building strong bones : molecular regulation of the osteoblast lineage", Nat Rev Mol Cell Biol, 13, pp.27~38 (2011)[DOI]
116. Yavropoulou MP, "The role of the Wnt signaling pathway in osteoblast commitment and differentiation", Hormones(Athens), 6, pp.279~294 (2007)[DOI]
117. Barton MJ, "The glia response after peripheral nerve injury : A comparison between schwann cells and olfactory ensheathing cells and their uses for neural regenerative therapies", Int J Mol Sci, 18 (2017)[DOI]
118. Dodo Y, "Myelination during fracture healing in vivo in myelin protein zero(p0)transgenic medaka line", Bone, 133, pp.115225~ (2020)[DOI]
119. Xie M, "Schwann cell precursors contribute to skeletal formation during embryonic development in mice and zebrafish", Proc Natl Acad Sci U S A, 116, pp.15068~15073 (2019)[DOI]
120. Dai ZM, "Stage-specific regulation of oligodendrocyte development by Wnt", β-catenin signaling, 2014, pp.34, 8467~8473
121. Grigoryan T, "Wnt", Rspondin, Proc Natl Acad Sci U S A, pp.2013, 110[DOI]
122. Tawk M, "Wnt", beta-catenin signaling is an essential and direct driver of myelin gene expression and myelinogenesis, 2011, pp.31, 3729~3742
123. Fancy SP, "Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS", Genes Dev, 23, pp.1571~1585 (2009)[DOI]
124. Silva-García O, "Wnt", β-catenin signaling as a molecular target by pathogenic bacteria, 2019, pp.10, 2135~
125. Wu D, "GSK3 : a multifaceted kinase in Wnt signaling", Trends Biochem Sci, 35, pp.161~168 (2010)[DOI]
126. MacDonald BT, "Wnt", beta-catenin signaling: Components, mechanisms, and diseases, 2009, pp.17, 9~26
127. Kobayashi Y, "Roles of Wnt signaling in bone formation and resorption", Jpn Dent Sci Rev, 44, pp.76~82 (2008)[DOI]
128. Borrell-Pages M, "LRP5 associates with specific subsets of macrophages : Molecular and functional effects", J Mol Cell Cardiol, 90, pp.146~156 (2016)[DOI]
129. Inestrosa NC, "Peroxisome proliferator-activated receptor gamma is expressed in hippocampal neurons and its activation prevents beta-amyloid neurodegeneration : role of Wnt signaling", Exp Cell Res, 304, pp.91~104 (2005)[DOI]
130. Du Q, "Cross-regulation between wnt and NF-κB signaling pathways", For Immunopathol Dis Therap, 1, pp.155~181 (2010)[DOI]
131. Liu L, "Dysfunctional Wnt", β-catenin signaling contributes to blood-brain barrier breakdown in Alzheimer’s disease, 2014, pp.75, 19~25
132. Purro SA, "Dysfunction of Wnt signaling and synaptic disassembly in neurodegenerative diseases", J Mol Cell Biol, 6, pp.75~80 (2014)[DOI]
133. Libro R, "The role of the Wnt canonical signaling in neurodegenerative diseases", Life Sci, 158, pp.78~88 (2016)[DOI]
134. Purro SA, "The secreted Wnt antagonist Dickkopf-1 is required for amyloid β-mediated synaptic loss", J Neurosci, 32, pp.3492~3498 (2012)[DOI]
135. Li W, "Intracerebroventricular injection of sclerostin reduced social hierarchy and impaired neuronal dendritic complexity in mice", Neurosci Lett, 773, pp.136514~ (2022)[DOI]
136. Borlongan CV, "The great migration of bone marrow-derived stem cells toward the ischemic brain : therapeutic implications for stroke and other neurological disorders", Prog Neurobiol, 95, pp.213~228 (2011)[DOI]
137. Zhao Y, "Inspiration for the prevention and treatment of neuropsychiatric disorders : New insight from the bone-brain-axis", Brain Res Bull, 177, pp.263~272 (2021)[DOI]
138. Chakari-Khiavi F, "Prospects for the application of mesenchymal stem cells in Alzheimer’s disease treatment", Life Sci, 231, pp.116564~ (2019)[DOI]
139. Qin C, "Transplantation of bone marrow mesenchymal stem cells improves cognitive deficits and alleviates neuropathology in animal models of Alzheimer’s disease : a meta-analytic review on potential mechanisms", Transl Neurodegener, 9, pp.20~ (2020)[DOI]
140. Ataka K, "Bone marrow-derived microglia infiltrate into the paraventricular nucleus of chronic psychological stress-loaded mice", PLoS One, 8, pp.e81744~ (2013)[DOI]
141. Jones KB, "Bone and brain: A review of neural, hormonal, and musculoskeletal connections", Iowa Orthop J, 24, pp.123~132 (2004)
142. Wan QQ, "Crosstalk between bone and nerves within bone", Adv Sci(Weinh), 8, pp.2003390~ (2021)[DOI]
143. Togari A, "The neuro-osteogenic network : The sympathetic regulation of bone resorption", Jpn Dent Sci Rev, 48, pp.61~70 (2012)[DOI]
144. Grässel SG, "The role of peripheral nerve fibers and their neurotransmitters in cartilage and bone physiology and pathophysiology", Arthritis Res Ther, 16, pp.485~ (2014)[DOI]
145. Hamdan TA, "The effect of denervation on fracture healing, an experimental study on rabbits", Basrah J Surg, 20, pp.3~9 (2014)[DOI]
146. Ducy P, "The two faces of serotonin in bone biology", J Cell Biol, 191, pp.7~13 (2010)[DOI]
147. Brakspear KS, "Glutamate signaling in bone", Front Endocrinol(Lausanne), 3, pp.97~ (2012)[DOI]
148. Motyl KJ, "A novel role for dopamine signaling in the pathogenesis of bone loss from the atypical antipsychotic drug risperidone in female mice", Bone, 103, pp.168~176 (2017)[DOI]
149. Zhu J, "Activation of dopamine receptor D1 promotes osteogenic differentiation and reduces glucocorticoid-induced bone loss by upregulating the ERK1", 2 signaling pathway, 2022, pp.28, 23~
150. Zhong Q, "Multiple melanocortin receptors are expressed in bone cells", Bone, 36, pp.820~831 (2005)[DOI]
151. Farooqi IS, "Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency", J Clin Invest, 106, pp.271~279 (2000)[DOI]
152. Sato S, "Central control of bone remodeling by neuromedin U", Nat Med, 13, pp.1234~1240 (2007)[DOI]
153. Mukohyama H, "The inhibitory effects of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide on osteoclast formation are associated with upregulation of osteoprotegerin and downregulation of RANKL and RANK", Biochem Biophys Res Commun, 271, pp.158~163 (2000)[DOI]
154. Li FX, "The role of substance P in the regulation of bone and cartilage metabolic activity", Front Endocrinol(Lausanne), 11, pp.77~ (2020)[DOI]
155. Sun S, "No pain, no gain? The effects of pain-promoting neuropeptides and neurotrophins on fracture healing", Bone, 131, pp.115109~ (2020)[DOI]
156. Herber CB, "Estrogen signaling in arcuate Kiss1 neurons suppresses a sex-dependent female circuit promoting dense strong bones", Nat Commun, 10, pp.163~ (2019)[DOI]
157. Herber CB, "Should we make more bone or not, as told by kisspeptin neurons in the arcuate nucleus", Semin Reprod Med, 37, pp.147~150 (2019)[DOI]
158. Kim JG, "AgRP neurons regulate bone mass", Cell Rep, 13, pp.8~14 (2015)[DOI]
159. Baliram R, "Thyroid-stimulating hormone induces a Wnt-dependent, feed-forward loop for osteoblastogenesis in embryonic stem cell cultures", Proc Natl Acad Sci U S A, 108, pp.16277~16282 (2011)[DOI]
160. DiGirolamo DJ, "Mode of growth hormone action in osteoblasts", J Biol Chem, 282, pp.31666~31674 (2007)[DOI]
161. Jiang YL, "The protective effects of osteocyte-derived extracellular vesicles against Alzheimer’s disease diminished with aging", Adv Sci(Weinh), 9, pp.e2105316~ (2022)[DOI]
162. Goulding SR, "The potential of bone morphogenetic protein 2 as a neurotrophic factor for Parkinson’s disease", Neural Regen Res, 15, pp.1432~1436 (2020)[DOI]
163. Shan C, "Roles for osteocalcin in brain signalling : implications in cognition-and motor-related disorders", Mol Brain, 12, pp.23~ (2019)[DOI]
164. Huang Y, "Dickkopf-1 : Current knowledge and related diseases", Life Sci, 209, pp.249~254 (2018)[DOI]
165. 송주현, "Perspectives in Lipocalin-2: Emerging Biomarker for Medical Diagnosis and Prognosis for Alzheimer's Disease", Clinical Nutrition Research, 7(1), pp.1~10 (2018), 한국임상영양학회
166. Komori T, "Functions of osteocalcin in bone, pancreas, testis, and muscle", Int J Mol Sci, 21 (2020)[DOI]
167. Oury F, "Maternal and offspring pools of osteocalcin influence brain development and functions", Cell, 155, pp.228~241 (2013)[DOI]
168. Qian Z, "Osteocalcin attenuates oligodendrocyte differentiation and myelination via GPR37 signaling in the mouse brain", Sci Adv, 7, pp.eabi5811~ (2021)[DOI]
169. Asimakopoulou A, "Lipocalin 2 in the pathogenesis of fatty liver disease and nonalcoholic steatohepatitis", Clin Lipidol, 10, pp.47~67 (2015)[DOI]
170. Dekens DW, "Lipocalin 2 as a link between ageing, risk factor conditions and age-related brain diseases", Ageing Res Rev, 70, pp.101414~ (2021)[DOI]
171. Petropoulou PI, "Lipocalin-2 is an anorexigenic signal in primates", Elife, 9 (2020)[DOI]
172. Li L, "Peripheral actions and direct central-local communications of melanocortin 4 receptor signaling", J Sport Health Sci (2021)[DOI]
173. Naudé PJ, "Lipocalin 2 : novel component of proinflammatory signaling in Alzheimer’s disease", FASEB J, 26, pp.2811~2823 (2012)[DOI]
174. Mesquita SD, "Lipocalin 2 modulates the cellular response to amyloid beta", Cell Death Differ, 21, pp.1588~1599 (2014)[DOI]
175. Tapia-Rojas C, "Loss of canonical Wnt signaling is involved in the pathogenesis of Alzheimer’s disease", Neural Regen Res, 13, pp.1705~1710 (2018)[DOI]
176. Ren C, "The role of DKK1 in Alzheimer’s disease : A potential intervention point of brain damage prevention?", Pharmacol Res, 144, pp.331~335 (2019)[DOI]
177. Laszczyk AM, "FGF-23 deficiency impairs hippocampal-dependent cognitive function", eNeuro, 6 (2019)[DOI]
178. Kunert SK, "Klotho and fibroblast growth factor 23 in cerebrospinal fluid in children", J Bone Miner Metab, 35, pp.215~226 (2017)[DOI]
179. Cuevas P, "Intravenous fibroblast growth factor penetrates the blood-brain barrier and protects hippocampal neurons against ischemia-reperfusion injury", Surg Neurol, 49, pp.77~83 (1998)[DOI]
180. Hsuchou H, "Fibroblast growth factor 19 entry into brain", Fluids Barriers CNS, 10, pp.32~ (2013)[DOI]
181. McGrath ER, "Circulating fibroblast growth factor 23 levels and incident dementia : The Framingham heart study", PLoS One, 14, pp.e0213321~ (2019)[DOI]
182. Wright CB, "Plasma FGF23 and the risk of stroke : The Northern Manhattan Study(NOMAS)", Neurology, 82, pp.1700~1706 (2014)[DOI]
183. Yu H, "The effect of osteopontin on microglia", Biomed Res Int, 2017, pp.1879437~ (2017)[DOI]
184. Sun Y, "Elevated osteopontin levels in mild cognitive impairment and Alzheimer’s disease", Mediators Inflamm, 2013, pp.615745~ (2013)[DOI]
185. Maetzler W, "Osteopontin is elevated in Parkinson’s disease and its absence leads to reduced neurodegeneration in the MPTP model", Neurobiol Dis, 25, pp.473~482 (2007)[DOI]
186. Filardi T, "High serum osteopontin levels are associated with prevalent fractures and worse lipid profile in post-menopausal women with type 2 diabetes", J Endocrinol Invest, 42, pp.295~301 (2019)[DOI]
187. Kichev A, "Implicating receptor activator of NF-κB(RANK)", RANK ligand signalling in microglial responses to toll-like receptor stimuli, 2017, pp.39, 192~206
188. Shimamura M, "OPG", RANKL, Proc Natl Acad Sci U S A, pp.2014, 111[DOI]
189. Hanada R, "Central control of fever and female body temperature by RANKL", RANK, 2009, pp.462, 505~509
190. Zhang J, "Beneficial effects of anti-RANKL antibody in depression-like phenotype, inflammatory bone markers, and bone mineral density in male susceptible mice after chronic social defeat stress", Behav Brain Res, 379, pp.112397~ (2020)[DOI]
191. Suzawa M, "Extracellular matrix-associated bone morphogenetic proteins are essential for differentiation of murine osteoblastic cells in vitro", Endocrinology, 140, pp.2125~2133 (1999)[DOI]
192. Baylink DJ, "Growth factors to stimulate bone formation", J Bone Miner Res, 8(Suppl 2), pp.S565~S572 (1993)[DOI]
193. Bond AM, "The dynamic role of bone morphogenetic proteins in neural stem cell fate and maturation", Dev Neurobiol, 72, pp.1068~1084 (2012)[DOI]
194. Jensen GS, "Bone morphogenetic proteins(BMPs)in the central regulation of energy balance and adult neural plasticity", Metabolism, 123, pp.154837~ (2021)[DOI]
195. Yakar S, "Insulin-like growth factors : Actions on the skeleton", J Mol Endocrinol, 61, pp.T115~t37 (2018)[DOI]
196. Gontier G, "Blocking IGF signaling in adult neurons alleviates Alzheimer’s disease pathology through amyloid-β clearance", J Neurosci, 35, pp.11500~11513 (2015)[DOI]
197. Wrigley S, "Insulin-like growth factor 1 : At the crossroads of brain development and aging", Front Cell Neurosci, 11, pp.14~ (2017)[DOI]
198. Downs M, "Mass spectrometry methods for analysis of extracellular matrix components in neurological diseases", Mass Spectrom Rev, pp.e21792~ (2022)[DOI]
199. Farr JN, "Identification of senescent cells in the bone microenvironment", J Bone Miner Res, 31, pp.1920~1929 (2016)[DOI]
200. Wang T, "Senescent cells : A therapeutic target for osteoporosis", Cell Prolif, 55, pp.e13323~ (2022)[DOI]
201. Bussian TJ, "Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline", Nature, 562, pp.578~582 (2018)[DOI]
202. Sikora E, "Cellular senescence in brain aging", Front Aging Neurosci, 13, pp.646924~ (2021)[DOI]
203. Basisty N, "A proteomic atlas of senescence-associated secretomes for aging biomarker development", PLoS Biol, 18, pp.e3000599~ (2020)[DOI]
204. Li KW, "Recent developments in data independent acquisition(DIA)mass spectrometry : Application of quantitative analysis of the brain proteome", Front Mol Neurosci, 13, pp.564446~ (2020)[DOI]
205. Koopmans F, "Comparative hippocampal synaptic proteomes of rodents and primates : Differences in neuroplasticity-related proteins", Front Mol Neurosci, 11, pp.364~ (2018)[DOI]
206. Cleland TP, "Bone protein extraction without demineralization using principles from hydroxyapatite chromatography", Anal Biochem, 472, pp.62~66 (2015)[DOI]
207. Lyon SM, "A method for whole protein isolation from human cranial bone", Anal Biochem, 515, pp.33~39 (2016)[DOI]
208. Shabestari M, "Altered protein levels in bone marrow lesions of hip osteoarthritis : Analysis by proteomics and multiplex immunoassays", Int J Rheum Dis, 23, pp.788~799 (2020)[DOI]
209. Schreiweis MA, "A proteomic analysis of adult rat bone reveals the presence of cartilage", chondrocyte markers, 2007, pp.101, 466~476
210. Colleary C, "Microwave-assisted acid hydrolysis for whole-bone proteomics and paleoproteomics", Rapid Commun Mass Spectrom, 34, pp.e8568~ (2020)[DOI]
211. Mickleburgh HL, "Human bone proteomes before and after decomposition : Investigating the effects of biological variation and taphonomic alteration on bone protein profiles and the implications for forensic proteomics", J Proteome Res, 20, pp.2533~2546 (2021)[DOI]
212. Bonicelli A, "Insights into the differential preservation of bone proteomes in inhumed and entombed cadavers from Italian forensic caseworks", J Proteome Res, 21, pp.1285~1298 (2022)[DOI]
213. Jiang X, "Method development of efficient protein extraction in bone tissue for proteome analysis", J Proteome Res, 6, pp.2287~2294 (2007)[DOI]
214. Creecy A, "Post-translational modifications in collagen type I of bone in a mouse model of aging", Bone, 143, pp.115763~ (2021)[DOI]
215. Bruderer R, "Optimization of experimental parameters in data-independent mass spectrometry significantly increases depth and reproducibility of results", Mol Cell Proteomics, 16, pp.2296~2309 (2017)[DOI]
216. Gillet LC, "Targeted data extraction of the MS", MS spectra generated by data-independent acquisition : a new concept for consistent and accurate proteome analysis, 2012, pp.11, 016717~
217. Pino LK, "Acquiring and analyzing data independent acquisition proteomics experiments without spectrum libraries", Mol Cell Proteomics, 19, pp.1088~1103 (2020)[DOI]
218. Collins BC, "Multi-laboratory assessment of reproducibility, qualitative and quantitative performance of SWATH-mass spectrometry", Nat Commun, 8, pp.291~ (2017)[DOI]
219. Rosenberger G, "A repository of assays to quantify 10,000 human proteins by SWATH-MS", Sci Data, 1, pp.140031~ (2014)[DOI]
220. Bons J, "Advances in protein molecular and structural biology methods", pp.311~326 (2022), Elsevier Inc
221. Bundgaard L, "Effective protein extraction combined with data independent acquisition analysis reveals a comprehensive and quantifiable insight into the proteomes of articular cartilage and subchondral bone", Osteoarthritis Cartilage, 30, pp.137~146 (2022)[DOI]
222. Rose JP, "Robust and highly efficient extractions of proteins from bones enable deep, high-throughput proteomic quantification to gain insights into bone biology", bioRxiv (2022)[DOI]

관련 논문AI추천